Trafalgar International GCAN
OTC GCAN
$0.35 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Trafalgar International (GCAN) Receivables - Other (2019 - 2020)

Trafalgar International (GCAN) posted Receivables - Other of $28000.0 for Q1 2020, little changed on a QoQ basis from $28000.0 in Q4 2019.

Analysis

Trafalgar International (GCAN) Receivables - Other (2019 - 2020) Analysis & Trends

Trafalgar International has reported Receivables - Other for 2 years, with the latest figure at $28000.0 in Q1 2020.

  • On a quarterly basis, Receivables - Other changed N/A year-over-year to $28000.0 in Q1 2020; TTM through Mar 2020 was $28000.0, a N/A change from a year earlier, with the FY2019 full-year figure at $28000.0, changed N/A from the prior year.
  • Receivables - Other was $28000.0 for Q1 2020 at Trafalgar International, roughly flat from $28000.0 in the prior quarter.
  • The five-year high for Receivables - Other was $28000.0 in Q4 2019, with the low at $28000.0 in Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn
10 Trafalgar International 217,335.05 217,335.05 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 28,000.00
Dec 31, 2019 28,000.00